Fructose-fed rats exhibited significant increase in body weight as compared to normal control rats (p < 0.05). Treatment with extracts in fructose-fed rats reversed this increase in body weight (p < 0.05). Fructose-fed rats were hyperglycemic and hyperinsulinemic as compared to normal control animals (p < 0.05). Treatment with extract in fructose-fed rats reduced glucose level without affecting insulin levels (p < 0.05) (
Table1). Fructose-fed animals exhibited significantly higher serum cholesterol, triglyceride, VLDL-cholesterol and LDL-cholesterol levels whereas there was a decrease in HDL-cholesterol and HDL-ratio as compared to normal control animals. Extract treatment in fructose-fed rats produced a significant decrease in serum cholesterol, triglycerides, VLDL-cholesterol and LDL-cholesterol levels, with an increase in HDL-cholesterol and HDL-ratio (
Table 1). Furthermore, extract treatment to fructose-fed rats exhibited significant improvement in atherogenic index (
Table 1).
Fructose-fed animals showed significant increase in lipid peroxidation in terms of malondialdehyde amount and superoxide dismutase (SOD) in liver tissue homogenates when compared to normal control animals. Treatment with extracts in fructose-fed rats significantly decreased lipid peroxidation and increased SOD in liver tissue homogenates (p < 0.05) (
Table 2). Fructose-fed rats showed significant decrease in catalase and glutathione levels in liver tissue homogenate in comparison with normal control animals. Treatment with extract significantly increased catalase and glutathione levels in liver tissue homogenate (p < 0.05) (
Table 2).
The prevalence of insulin resistance and associated diseases has risen seriously around the world. The general view of insulin action places this hormone at the point of multiple organ adaptations to the ingested nutrients, in particular, dietary carbohydrates. It has been established that insulin resistance, impaired glucose tolerance, hyperinsulinemia, hypertension and hyperlipidemia are associated with fructose intake in animal models. Increasing the dietary fructose consumption might be one of the factors responsible for the development of obesity and the accompanying insulin resistance syndrome (
14). Thus, the rats received 3 weeks of fructose-rich water could be served as a reliable model for the investigation of insulin resistance (
15).
The mechanism of glucose lowering action might involve proceedings other than pancreatic
β cells insulin secretion since we did not observe any improvement in insulin resistance in our study. Fructose-fed rats exhibited clear cut abnormalities in lipid metabolism as a proof for a significant elevation of plasma total cholesterol, triglycerides, LDL-C, atherogenic index and reduction of HDL-C levels. Treatment with aqueous extract of
Mentha piperita leaves’ extract for 21 days significantly reduced serum total cholesterol, triglycerides and LDL-C associated with concomitant significant increase in HDL-C levels and decrease in atherogenic index in hyperlipidemic rats indicating its potent antihyperlipidemic and antiatherogenic activity. The glucose lowering action of extract can be due to the improved lipid metabolism apart from the direct interaction with glucose homeostasis. The triglyceride lowering properties (activity) of extract can indirectly contribute to the overall antihyperglycemic activity through a mechanism called glucose-fatty acid cycle (
16,
17). According to the Randle’s glucose-fatty acid cycle, increased supply of plasma triglycerides per se can constitute a source of increased free fatty acid (FFA) availability and oxidation that can impair insulin action, glucose metabolism and utilization leading to development of hyperglycemia. It has been postulated that fructose can accelerate free radical production similar to glucose. For example, Suzuki K (
18) has observed an increased production of H
2O
2 and formation of hydroxyl radicals by hamster pancreatic cells incubated with fructose in the presence of a metal ion catalyst. Furthermore, due to hyperglycemia, an increase in non-enzymatic glycosylation occurs, accompanied with glucose oxidation and these reactions are catalyzed by Cu
+2 and Fe
+2, resulting in formation of O
2 - and OH radicals which further accelerates the risk of cardiac diseases in dyslipidemia (
19). Lipid peroxidation is one of the characteristic features of chronic fructose consumption. In this context, a marked increase in the concentration of TBARS was observed in liver of fructose-fed rats. Increased lipid peroxide concentration in the liver of fructose-fed animals has already been reported (
20). Administration of the extract significantly decreased the levels of TBARS in fructose-fed rats (
Table 2). Glutathione (GSH), a tripeptide present in all the cells is an important antioxidant. Decreased glutathione levels in fructose-fed animals have been considered to be an indicator of increased oxidative stress. GSH also acts as a free radical scavenger in the repair of radicals caused biological damage. A decrease was observed in liver GSH in fructose-fed animals. Administration of the extract increased the content of GSH in liver of fructose-fed rats (
Table 2). The cellular radical scavenging systems include the enzymes such as superoxide dismutase (SOD), which scavenges the superoxide ions by catalyzing its dismutation and catalase (CAT), a heme enzyme which removes hydrogen peroxide. Therefore, reduction in the activity of these enzymes (SOD, CAT) results in a number of deleterious effects due to the accumulation of superoxide anion radicals and hydrogen peroxide. Administration of aqueous extract increased the activity of SOD and catalase in fructose-fed rats. Since the extract showed
in-vivo antioxidant activity in fructose-fed rats, improvement of the liver functions and the subsequent increase in the uptake and utilization of blood glucose might be the mechanism of action of this extract as glucose lowering and hypolipidemic agent.